Atlas Trials

Immunic AG

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Immunic AG

RecordFirmDate
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis (NCT05201638)Immunic AG2022-01-12
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer (NCT05124795)Immunic AG2021-12-09
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis (NCT05054140)Immunic AG2021-09-30
A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) (NCT04379271)Immunic AG2020-06-11
MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) (NCT03846219)Immunic AG2019-01-28
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis (NCT03341962)Immunic AG2018-03-15

Track Immunic AG automatically

Every clearance here is in the API, with alerts when new ones post.